Latest News about UK:GSK
Recent news which mentions UK:GSK
Tags
   UK:GSK
  
  From MarketWatch
 
   Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
   
  
  
  April 18, 2023
  From MarketWatch
 
   GSK to acquire U.S.-based BELLUS Health for $14.75 per share
   
  
  
  April 18, 2023
  From MarketWatch
 
   GSK reports positive phase 3 data for UTI oral antibiotic
   
  April 17, 2023
  Tags
   UK:GSK
  
  From MarketWatch
 
   FTSE 100 hits fresh record above 8,000 on weak pound and renewed demand for energy stocks
   
  
  
  February 16, 2023
  From MarketWatch
 
   GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
   
  February 01, 2023
  Tickers 
   GSK
  
  
  From MarketWatch
 
   Moderna is the latest company to produce a promising RSV vaccine
   
  
  
  January 18, 2023
  From MarketWatch
 
   Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
   
  
  
  January 09, 2023
  From MarketWatch
 
   Get ready for a ‘conundrum’ of a respiratory illness season
   
  December 07, 2022
  Tickers 
   PFE
  
  
  From MarketWatch
 Tickers 
   GSK
  
  
  From MarketWatch
 
   GSK to withdraw Blenrep’s U.S. marketing authorization after FDA request
   
  November 22, 2022
  Tags
   UK:GSK
  
  From MarketWatch
 
   China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
   
  November 11, 2022
  Tickers 
   GSK
  
  
  From MarketWatch
 From MarketWatch
 Tickers 
   GSK
  
  
  From MarketWatch
 Tickers 
   GSK
  
  
  From MarketWatch
 Tags
   UK:GSK
  
  From MarketWatch
 From MarketWatch
 
   AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
   
  
  
  September 14, 2022
  From MarketWatch
 From MarketWatch
 
   GSK defends Zantac ahead of trials that have cratered the stock
   
  
  
  August 12, 2022
  From MarketWatch
 Tags
   UK:GSK
  
  From MarketWatch
 From MarketWatch
 Tickers 
   GSK
  
  
  From MarketWatch
 
   GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
   
  
  
  April 13, 2022
  From MarketWatch
 
   BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
   
  
  
  April 06, 2022
  From MarketWatch
 
   WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
   
  
  
  March 30, 2022
  From MarketWatch
 
   CDC expected to loosen COVID face-mask advice later Friday, and Canada authorizes first plant-based vaccine
   
  February 25, 2022
  Tickers 
   GSK
  
  
  From MarketWatch
 
   WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths
   
  
  
  February 23, 2022
  From MarketWatch
 From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.